NCT06824727View on ClinicalTrials.gov

Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

August 21, 2025

Study Completion Date

August 21, 2025

Conditions
Thrombocytopenia
Interventions
OTHER

Baseline cell blood counts

Obtain one peripheral blood sample from participants who have severe thrombocytopenia defined as 30,000 platelets/mcl or less

Trial Locations (1)

44195

Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT06824727 - Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia | Biotech Hunter | Biotech Hunter